Global Allergy Diagnostics Market: Greater Susceptibility to Allergies in Developed Countries Catapults Demand, finds TMR

The global allergy diagnostics market is immensely consolidated, with the top five players accounting for around 73.0% in 2015. Thermo Fisher Scientific Inc., Quest Diagnostics, Inc., BioMerieux, Omega Diagnostics Group Plc., and Stallergenes Greer dominated the global market that year. Transparency Market Research notes that the market for allergy diagnostics displays intense rivalry among existing players owing to the presence of several large global players and a few local companies.

Collaborations with leading firms to enter new markets has been noted to be a successful growth strategy adopted by dominant players. A case in point would be Quest Diagnostics. Given the role of genetics in developing allergies, the company collaborated with AncestryDNA in August 2016 to help meet the rapidly growing consumer demand for genetic tests. This collaboration is likely to allow Quest Diagnostics to expand its product portfolio in the in-vitro testing segment.

The opportunity presented by the global market was pegged at US$1.3 bn in 2015 and is projected to be worth US$3.8 bn by 2024, expanding at a strong CAGR of 12.8% therein.

Download Exclusive Brochure of This Report :

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5147

Diagnostic Laboratories Leading End Users of Allergy Diagnostics

The consumables segment accounted for the major share in the allergy diagnostics market. The segment is projected to present a 50.1% share by 2024, registering the highest CAGR of 13.6% during the forecast period. The instruments segment, on the other hand, is projected to witness sluggish growth through 2024. By allergen type, the inhaled allergens segment accounted for the dominant share in the allergy diagnostics market, with the food allergens segment expected to register a high CAGR from 2016 to 2024.

Based on test, in vivo tests led the market while in vitro tests present the most attractive growth opportunities. Diagnostic laboratories are the leading end users of allergy diagnostics and are also likely to exhibit the strongest growth during the course of the forecast period.

Taking the lead from a geographical standpoint, North America is forecast to account for 39.9% of the global allergy diagnostics market by 2024. On the other hand, Asia Pacific will register the most promising CAGR of 13.6% during the forecast period.

Growing Prevalence of Allergy Diseases in the Western World

Apart from the growing prevalence of allergies across the globe, the allergy diagnostics market is fueled by a number of genetic, geographical, social, and economic factors.

A theory key to the development of the allergy diagnostics market is the “hygiene hypothesis”. This hypothesis states that the lack of early exposure to infectious agents and microorganisms increases the susceptibility of a person to allergies, by restricting the early development of the immune system. According to the theory, the urban and western lifestyle, with its limited exposure to infectious agents in childhood, is highly responsible for the increased prevalence of allergies in countries in the West. Supporting this theory are statistics revealed by the Global Burden of Asthma. In 2013, figures showed that the U.S., Australia, New Zealand, and the U.K. had a 20 times higher prevalence of allergies than other countries. This, in turn, has been driving the demand for allergy diagnostics in these countries.

An alarming rise in pollution levels, genetic factors responsible for the proneness to allergies, the availability of advanced technologies for allergy diagnostics, and increased healthcare expenditure worldwide are also contributing toward the growth of the allergy diagnostics market.

This review is based on the findings of a TMR report titled “Allergy Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Global Allergy Diagnostics Market, by Product

Assay Kits
Consumables
Instruments
Global Allergy Diagnostics Market, by Allergen Type

Inhaled Allergens
Food Allergens
Drug Allergens
Others
Global Allergy Diagnostics Market, by Tests

In-vivo tests
In-vitro tests
Global Allergy Diagnostics Market, by End Users

Hospitals
Diagnostic Laboratories
Academic Research Institutes
Others
Global Allergy Diagnostics Market, by Geography

North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
UAE
Rest of Middle East & Africa
Browse Global Strategic Business Report: http://www.transparencymarketresearch.com/allergy-diagnostics-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.